Oncolytic virus therapy uses viruses that preferentially infect and kill cancer cells. These viruses are often genetically modified to enhance their cancer-targeting abilities and to stimulate a broader immune response. An example is talimogene laherparepvec (T-VEC), used in the treatment of melanoma.